Erly® Prefilled Pen (Liraglutide Injection)

Erly® Prefilled Pen is a prescription injectable formulation containing Liraglutide, a GLP-1 receptor agonist used in the management of type 2 diabetes mellitus and to support weight control in eligible patients. It works by improving insulin secretion, reducing excess glucose production, slowing gastric emptying, and helping regulate appetite.

Erly Prefilled Pen is designed for once-daily subcutaneous administration using a convenient, patient-friendly pen device. It is suitable for adults requiring improved glycemic control alongside diet and lifestyle modification.

This product is widely demanded in emerging and regulated markets for diabetes and metabolic care.
Medicina Overseas supplies Erly® Prefilled Pen for international export, supporting pharmacies, distributors, hospitals, and bulk importers with reliable sourcing and documentation.

⚠️ Prescription-only medicine. To be used under medical supervision.

✅ KEY BENEFITS (OPTIONAL – HIGH CONVERSION)

• Helps control blood glucose levels

• Supports appetite regulation & weight management

• Easy-to-use prefilled injection pen

• GLP-1 receptor agonist therapy

• Suitable for long-term metabolic care